From: The role of endoscopy and findings in COVID-19 patients, an early North American Cohort
Procedure | Â | |||
---|---|---|---|---|
Endoscopy, n (%) | 18 (75) | |||
Colonoscopy, n (%) | 7 (29.2) | |||
ERCP, n (%) | 2 (8.3) | |||
Type of sedation, n (%) | Conscious | 6 (25) | ||
MAC | 8 (33.3) | |||
General | 10 (41.7) | |||
Reason for endoscopy | Â | |||
 Need for enteral access, n (%) | 6 (25) | |||
 Overt Bleeding, n (%) | 13 (54.2) | |||
 Anemia without overt bleeding, n (%) | 1 (4.2) (OGT placed during EGD as well) | |||
 Biliary decompression, n (%) | 2 (8.3) | |||
 Diarrhea, n (%) | 1 (4.2) | |||
 Obstruction, n (%) | 1 (4.2) | |||
Need for intervention, n (%) | GI Bleed | 2 (8.3) | ||
Enteral feeding access | 6 (25) | |||
Biliary decompression | 2 (8.3) | |||
Endoscopic findings | Â | |||
 Endoscopy n = 18, n (%) | Enteral tube placement | 6 (33.3) | ||
Inflammation/ulcers | 10 (55.6) | |||
AVM | 1 (5.6) | |||
Varices | 1 (5.6) | |||
Normal | 1 (5.6) (one for OGT placement) | |||
 Colonoscopy n = 7, n (%) | Diverticulosis | 2 (8.6) | ||
Hemorrhoids | 3 (42.9) | |||
Rectal ulcer | 1 (14.3) | |||
Blood without source | 1 (14.3) | |||
Normal | 1 (14.3) | |||
 ERCP n = 2, n (%) | Choledocholithiasis | 1 (50) | ||
Biliary Sludge | 1 (50) | |||
 Related to COVID, n (%) | Yes | 2 (8.3) | ||
No | 22 (91.7) |